Skip to content

Implementation of a new delirium prevention bundle for mechanically ventilated patients in ICU

To determine whether implementation of a new ICU delirium prevention bundle will reduce the incidence of delirium compared to standard of care protocol in mechanically ventilated patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007904
Enrollment
50
Registered
2017-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients admitted to the ICU who are mechanically ventilated Health Condition 2: J969- Respiratory failure, unspecified

Interventions

Intervention1: Sleep quality improvement, Analgesia and sedation, Family contacts and bonding, Early mobilization, Weaning from ventilator, Early removal of catheters, Antipsychotics, No benzodiazepin
it should be done under adequate analgesia and sedation. (2) Analgesia and sedation: a) Analgesia-first sedation: Pain will be assessed using Critical- Care Pain Observation Tool (CPOT) 55, 56 and it

Sponsors

Anil Kumar Malik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) All adult patients with age more than 18 years (2) Requirement of mechanical ventilation for more than 24 hours

Exclusion criteria

Exclusion criteria: (1) History of prior neurological or psychiatric disorders (2) Patients with poor irreversible neurological status at the time of ICU admission (3) Patients with traumatic brain injury (4) Patient already having delirium at the time of ICU admission

Design outcomes

Primary

MeasureTime frame
Incidence of delirium between the new ICU delirium prevention bundle group and standard of care protocol groupTimepoint: 28 days

Secondary

MeasureTime frame
Comparison of incidence of the following outcomes: 1. Duration of mechanical ventilation 2. ICU length of stay 3. 28 day mortality rate 4. Any other adverse events Timepoint: 28 days

Countries

India

Contacts

Public ContactAnil Kumar Malik

AIIMS, New Delhi

drsrajeshwari@gmail.com9810079229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026